NCT07369934 Virtual Reality Based Exercise Training Versus Mulligan Mobilization on Shoulder Posture and Function in Subacromial Impingement Syndrome
| NCT ID | NCT07369934 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cairo University |
| Condition | Subacromial Impingement Syndrome |
| Study Type | INTERVENTIONAL |
| Enrollment | 74 participants |
| Start Date | 2025-12-13 |
| Primary Completion | 2026-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 74 participants in total. It began in 2025-12-13 with a primary completion date of 2026-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study will compare the effect of virtual reality based exercise training versus Mulligan mobilization in addition to exercise therapy added to both groups on shoulder posture and function in subacromial impingement syndrome.
Eligibility Criteria
Inclusion Criteria: * Patients will be referred from the orthopedic surgeon with a diagnosis of stage II SIS with the following criteria: 1. Participants ranged in age from 30-50 years old. 2. Participants are from non-athletes from the general population. 3. Unilateral shoulder pain that is localized either anteriorly or laterally to the acromion. Pain that occurs or worsens when the affected shoulder is in flexion and/or abduction. 4. Four of the following should be present in the included patients: Neer impingement test, Hawkins' test, Pain was replicated in the supraspinatus empty-can test, a painful arc of movement from 70° to 120°, and painful greater tuberosity of the humerus. 5. BMI range 18.5- 29.9 Kg/m². Exclusion Criteria: * 1\) Patients who, during the previous three months, underwent shoulder physical treatment and/or an acute pain flare. 2\) Patients who have undergone surgeries for tendon repair. 3) Malignancy, epilepsy, pregnant women, and/or systemic conditions like chronic renal or liver failure. 4\) Mini-Mental State Examination test (MMSE) (\< 24/30) to exclude cognitive impairment and/or significant vision impairment (if they couldn't read the introduction while wearing the Head Mounted Device (HMD). 5\) Corticosteroid injection during the last three months or used steroids chronically. 6\) Adhesive capsulitis, glenohumeral joint instability, Numbness or tingling of the upper limb, and/or full-thickness tear of the rotator cuff.
Contact & Investigator
Enas Fawzy Youssed, Professor Doctor
STUDY CHAIR
Cairo University
Frequently Asked Questions
Who can join the NCT07369934 clinical trial?
This trial is open to participants of all sexes, aged 30 Years or older, up to 50 Years, studying Subacromial Impingement Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07369934 currently recruiting?
Yes, NCT07369934 is actively recruiting participants. Contact the research team at sara.mohsen@cu.edu.eg for enrollment information.
Where is the NCT07369934 trial being conducted?
This trial is being conducted at Giza, Egypt.
Who is sponsoring the NCT07369934 clinical trial?
NCT07369934 is sponsored by Cairo University. The principal investigator is Enas Fawzy Youssed, Professor Doctor at Cairo University. The trial plans to enroll 74 participants.